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Accepted 8 June 2012AbstractObjective: Simple guidelines for calculating efficient sample sizes in cluster randomized trials with unknown intraclass correlation
(ICC) and varying cluster sizes.
Methods: A simple equation is given for the optimal number of clusters and sample size per cluster. Here, optimal means maximizing
power for a given budget or minimizing total cost for a given power. The problems of cluster size variation and specification of the ICC of
the outcome are solved in a simple yet efficient way.
Results: The optimal number of clusters goes up, and the optimal sample size per cluster goes down as the ICC goes up or as the
cluster-to-person cost ratio goes down. The available budget, desired power, and effect size only affect the number of clusters and not the
sample size per cluster, which is between 7 and 70 for a wide range of cost ratios and ICCs. Power loss because of cluster size variation
is compensated by sampling 10% more clusters. The optimal design for the ICC halfway the range of realistic ICC values is a good
choice for the first stage of a two-stage design. The second stage is needed only if the first stage shows the ICC to be higher than
assumed.
Conclusion: Efficient sample sizes for cluster randomized trials are easily computed, provided the cost per cluster and cost per person
are specified.
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The effects of interventions to improve health or change
lifestyle are often evaluated with a cluster randomized trial
[1,2], also known as group randomized trial [3]. In such
a trial, organizations (clusters) are randomly assigned to
one of the treatment conditions, and all persons sampled
within a given cluster get the same treatment. Examples
from primary care are patient-centered care of newly diag-
nosed diabetes [4] and detection and treatment of depres-
sion [5] in general practice. Examples from public health
are smoking prevention [6] and stress management [7] in
primary school. Cluster randomization is less efficient
than individual randomization because outcome variationThe authors declare that neither any conflicts of interest nor any finan-
cial interests are involved in this submission. Funding for this study was
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Open access under the Elsevier OA license.between clusters, reflected by the so-called intraclass corre-
lation (ICC), increases the sampling error of the treatment
effect estimate in a cluster randomized trial [8e11]. How-
ever, such trials are needed for logistic reasons or to prevent
treatment contamination. Individual assignment is impossi-
ble for treatments such as health promotion in classrooms.
For other treatments, it may induce serious treatment
contamination.
Because cluster randomized trials are less efficient but
sometimes the only option, it is important to optimize their
efficiency. This is the topic of this article. Sample sizes
(number of clusters and number of persons per cluster) will
be presented that minimize the sampling error, thereby
maximizing test power and precision of estimation, for
treatment effects, under the constraint of a given budget
for sampling and measuring clusters and persons. Here,
budget is in terms of money, but it can also be expressed
as time or demands on participants. Equal sample sizes
per cluster will first be assumed for simplicity and because
they are the most efficient. Later, this assumption is re-
laxed. To prevent misunderstanding, we emphasize that this
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Key findings
 Efficient sample sizes for a cluster randomized trial
can be easily computed given the cost per cluster
and cost per person and given a range of realistic
intraclass correlations (ICCs).
What this adds to what was known?
 We do not need to know the precise ICC, and we
can easily compensate for varying cluster sizes.
Furthermore, the effect size determines the number
of clusters needed but not the sample size per
cluster.
What is the implication and what should change
now?
 Researchers must determine the cost per cluster
and cost per person before study design. They must
also report these costs and the outcome ICC and
variance to improve the planning of future trials.article is about sampling large clusters such as general prac-
tices and sampling persons from these clusters and not
about sampling small clusters such as families and then
including all its members. The outline of this article is as
follows. First, the optimal sample size for a cluster random-
ized trial is given as a function of the ICC of the outcome
and the costs per included cluster and per person. Second,
an equation is given to calculate the sample size and the
budget needed for a given power and effect size. Third,
simple solutions to two problems are given: uncertainty
about the ICC and varying cluster sizes. Finally, the theory
is applied to a published trial.2. Optimal sample size and power calculation
Suppose we have a cluster randomized trial with K clus-
ters of n persons per cluster and a quantitative outcome y
like body mass index or a clinical questionnaire score.
The data can be analyzed not only by a mixed (multilevel)
regression but also by an unpaired t-test on the K cluster
means, obtained by averaging individual outcomes within
each cluster. The latter method is equivalent to mixed re-
gression of the individual data if the sample size is the same
for each cluster and there are no covariates [11]. Varying
cluster sizes and covariates are discussed later. In a trial,
we want to estimate the treatment effect as precisely, and
to test it with as much power, as possible. So a good crite-
rion for the design efficiency is the variance (squared stan-
dard error [SE2]) of the estimated treatment effect, which is
expressed as follows [8e10]:E25
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arm, nK is the total sample size of the trial, and r is the
ICC, which is the proportion of outcome variance that is be-
tween clusters rather than between individuals within clus-
ters. The first half of the equation shows that the total
variance of the treatment effect is the sum of sampling error
between clusters and that within clusters. The factor ½ðn
1Þrþ 1 in the last half of the equation is known as the de-
sign effect (DE). Dividing the total sample size nK by the
DE gives the effective sample size, that is, the sample size
needed for individual randomization to have the same
power and precision as the cluster randomized trial. If the
ICC is 0, the DE is 1 and the SE of the treatment effect with
cluster randomization is equal to that with individual ran-
domization, as there is no outcome variation at the cluster
level then. As the ICC increases, so do the DE and SE of
the treatment effect.
Increasing either the cluster size n or the number of clus-
ters K decreases the SE and thus improves power and pre-
cision. Increasing n also increases the DE and is thus less
effective than increasing K. On the other hand, increasing
the number of clusters K may be very expensive. So the
question is, ‘‘What is the best choice of n and K for a given
trial?’’ This is addressed by optimal design theory [12]:
how to find that n and K which minimize the SE in Equa-
tion (1), thus maximizing power and precision, for a given
total sampling cost? Or equivalently, which n and K mini-
mize the total cost for a target SE, power, and precision?
To find this optimal design, we need a function that relates
sample size to costs. Assume that inclusion of a cluster into
the study costs c units (of money, time, or demands),
whereas inclusion of a person in an included cluster costs
s units. The budget B needed for K clusters of n persons,
ignoring those costs that do not depend on sample size, is
then B5cK þ snK5Kðcþ snÞ, where (cþ sn) is the total
sampling cost per cluster with sample size n. The optimal
design minimizes the SE of the treatment effect as a func-
tion of n and K, given the budget constraint B5Kðcþ snÞ.
Fig. 1 shows how the SE depends on the cluster size n for
various ICC values. The cluster size that gives the smallest
SE for a given ICC is the optimal design for that ICC. Note
that the SE does not continue to decrease as n increases be-
cause an increase of n implies a decrease of K because of
the budget constraint. The SE is minimal for the following
cluster size [9,10]:n5
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð1 rÞc
rs
s
ð2Þand the number of clusters then can be calculated as
K5 B / (cþ sn). So the optimal sample size per cluster de-
creases as the ICC goes up and increases as the cluster-to-
person cost ratio c/s goes up. Because of the budget
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Fig. 1. SE of the treatment effect in a cluster randomized trial as
a function of the cluster size (n) and ICC (r) under the budget con-
straint B5K (cþ sn), where B5 budget, K5 number of clusters,
c5 cost per cluster, and s5 cost per person (outcome variance
s2y5100, B5 10,000, c5 300, and s5 10). Dotted lines indicate
the optimal design per ICC. SE, standard error; ICC, intraclass
correlation.
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effects: it goes up with the ICC and goes down as the cost
ratio c/s increases. Note that the budget B affects the opti-
mal number of clusters but not the optimal cluster size,
which only depends on the ICC and the cost ratio. Fig. 2
shows the relation between the ICC and the optimal cluster
size for three cost ratios.
Inserting Equation (2) into Equation (1) gives the SE2
for the optimal design and thus the smallest possible SE
and largest possible power and precision, given the budget,
sampling costs, outcome variance, and ICC. If that SE is
still too large for sufficient power and precision, then the
budget must be increased, resulting in more clusters rather
than in more persons per cluster (Equation (2)). More
specifically, given a cluster size of n persons, the number
of clusters K needed for a power (1 g), two-tailed type
I error risk a, and effect size d5
m1  m2
sy
where m1 m2 is
the mean outcome difference between treatments [13] is
given by1
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Optimal cluster size in a cluster randomized trial as a function
intraclass correlation r for several ratios of cost per cluster c to
er person s.where DE is the design effect, Z1  g is the 100 (1 g)th
percentile of the standard normal distribution (e.g., 1.28
for a power of 90%), and Z1  a / 2 is the 100 (1 a / 2)th
percentile (e.g., 1.96 if a5 0.05 two tailed). The required
budget B is then K (cþ sn), the number of clusters times
the total cost per cluster. By substituting Equation (2) for
n in Equation (3), we minimize the budget, given the effect
size, power, and a. Note that multiplying both sides of
Equation (3) by n and then dividing both sides by the DE
give the total sample size needed for a standard randomized
controlled trial (RCT) without nesting.3. Coping with the unknown ICC
As Equation (1) and Fig. 1 show, the SE of the treatment
effect increases with the ICC, and so a safe strategy is to
use the optimal design for the largest realistic ICC based
on published trials. However, this may require a large bud-
get, as it follows from Equation (3) that K and thus B in-
creases with the ICC. A less-expensive and still safe
choice is to assume an intermediate ICC like the midpoint
of the assumed ICC range, for instance, 0.05 if the range is
0e0.10 as suggested by reviews of ICC values in primary
care trials [14,15]. This leads to a smaller B for a given
power and effect size. This can then be used in a two-
stage design as follows. First, we apply the optimal design
and budget needed for the midpoint ICC scenario. Then, we
estimate the ICC from the data to recalculate the number of
clusters needed, leading to more clusters (which requires
more budget) only if the ICC is higher than the midpoint.
According to a recent review [16], the final analysis can
usually be done on all data without correction for this in-
terim look and sample size recalculation based on the
ICC. This review concerned the unpaired t-test in a classic
RCT, but it also applies to cluster randomized trials ana-
lyzed with a t-test on cluster means, which is equivalent
to mixed regression of individual data [11]. Furthermore,
a simulation study by Lake et al. [17] (Table 1) suggests
that the present two-stage approach is safe in controlling
the type I error risk and power.
So instead of taking the number of clusters needed for
the maximum possible ICC, we take the number needed
for the midpoint ICC, thus saving costs if data analysis of
the first stage confirms the midpoint ICC. To see how much
can be saved, we computed the percentage extra budget
needed for the one-stage design based on the maximum
ICC relative to the first stage of the two-stage design based
on the midpoint ICC. Fig. 3A shows that much can be saved
especially if the ICC range or cost ratio is large. Of course,
the actual savings depend on the ICC value obtained in the
interim analysis. Fig. 3A shows the savings if the ICC turns
out to be smaller than, or equal to, the midpoint so that no
second stage is needed. If the ICC is larger, a second stage
with extra clusters is needed, increasing the costs for the
two-stage design. We therefore also computed the expected
Table 1. Number of clusters K, cluster size n, and budget B needed by the actual and optimal designs of the diabetes trial, for a power
of 90% to detect a treatment effect of size d5 0.50 (medium), with a5 5% two tailed, for various cost ratios c/s and ICCs, assuming cost
s5 10 per patient (n and K rounded to the nearest integer; changing s and c while fixing c/s, or changing d, the power, or a, changes both
budgets proportionally)
Cost ratio c/s ICC
Actual design
(n, K ) Actual budget B
Optimal design
(n, K ) Optimal budget B
Percentage extra
budget needed
5 0.02 6, 31 3,410 16, 14 2,940 16
0.05 6, 35 3,850 10, 24 3,600 7
0.10 6, 42 4,620 7, 38 4,560 1
20 0.02 6, 31 8,060 31, 9 4,590 76
0.05 6, 35 9,100 19, 17 6,630 37
0.10 6, 42 10,920 13, 28 9,240 18
50 0.02 6, 31 17,360 49, 7 6,930 250
0.05 6, 35 19,600 31, 14 11,340 73
0.10 6, 42 23,520 21, 24 17,040 38
Abbreviation: ICC, intraclass correlation.
The last column shows the percentage extra budget needed for the actual design compared with the optimal design.
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ICC design relative to the two-stage midpoint ICC design,
assuming that all ICC values from 0 to the maximum are
equally likely. The resulting percentages are plotted in
Fig. 3B and are two-thirds of those in Fig. 3A.0
10
20
30
40
50
60
70
0,01 0,05 0,10 0,15 0,20 0,25 ICC
range
c/s = 5
M
ax
im
um
 %
 e
xt
ra
 b
ud
ge
t n
ee
de
d
c/s = 20
c/s = 50
0
10
20
30
40
50
60
70
0,01 0,05 0,10 0,15 0,20 0,25 ICC
range
c/s = 5
Ex
pe
ct
ed
%
 e
xt
ra
 b
ud
ge
t n
ee
de
d
c/s = 20
c/s = 50
B
A
Fig. 3. A. Maximum percentage extra budget needed for a one-stage
maximum ICC design compared with a two-stage design based on
the midpoint ICC in the first stage as a function of the ICC range,
for several cost ratios c/s. B. The expected percentage extra budget
needed for a one-stage maximum ICC design vs. a two-stage design
based on the midpoint ICC in the first stage, if all ICC values from
0 to the maximum are equally likely so that the second stage is
needed with 50% chance. The expected percentages are two-thirds
of the maximum percentages shown in (A). ICC, intraclass correlation.Now, there is a chance that the maximum ICC is correct,
and then we loose efficiency by choosing the midpoint ICC
for the first stage because the optimal design (i.e., cluster
size) for the first stage is then not optimal after all. How-
ever, this loss is very small. If the maximum ICC is correct,
the design based on the midpoint ICC needs at most 5%
more budget than the correct design to have the same power
and precision, as we verified for all cost ratios between 1
and 50 and for all maximum ICCs from 0.01 to 0.25.
Modifications of the two-stage approach are conceiv-
able. For instance, instead of using the interim ICC point
estimate for planning the second stage, one may use the up-
per boundary of the 95% confidence interval for the ICC to
be safe. The price for this safety is a larger number of clus-
ters and a higher budget and [17] suggests that using the
point estimate is safe enough. Another modification would
be to reestimate the ICC and sample size already during in-
stead of after the first stage and allowing the number of
clusters to become smaller instead of larger than initially
planned [17]. However, this is beyond the present scope,
as our aim is to give simple guidelines for efficient trial
design.
In summary, we can save a lot and loose a little by
choosing a two-stage design with the first stage based on
the midpoint ICC instead of a one-stage design based on
the maximum ICC. So the two-stage design is a good
choice if clusters are enrolled in stages for logistic reasons
anyhow or if stagewise recruitment with sample size reesti-
mation after the first stage is not more expensive than the
simultaneous recruitment.4. Coping with varying cluster sizes
Our equations assume each of the K clusters to be of the
same size. In practice, the cluster size varies because gen-
eral practices and schools vary in size and because of re-
cruitment problems and individual dropout. Instead of
a simple t-test on cluster means, we then need either mixed
(multilevel) regression of individual data or weighted least
1216 G.J.P. van Breukelen, M.J.J.M. Candel / Journal of Clinical Epidemiology 65 (2012) 1212e1218squares analysis of cluster means [18]. Furthermore, the
cluster size variation causes some efficiency loss. This
can be compensated by sampling more clusters. To know
how many more clusters, we have to know the relative ef-
ficiency (RE) of varying vs. equal cluster sizes. A simple
and popular approximation to this RE is based on the as-
sumption of an ICC close to 0 [19e21]. However, this ap-
proximation is much too pessimistic, and combining it with
an approximation for large ICCs shows that the RE can
never be smaller than minRE5
2
2þ CV2 [18]. Here, CV is
the coefficient of variation (i.e., standard deviation/mean)
of the cluster sizes. Another approximation was also de-
rived, by which minRE is 1 CV2 / 4, and the accuracy
of this result was confirmed for both large [18] and small
[22] samples.
Using these two expressions for the minimum RE of
varying cluster sizes, minRE, of which the first is still too
pessimistic and the second a bit too optimistic, we can ad-
just for the efficiency loss because of cluster size variation
by multiplying the number of clusters with 1/minRE. In
practice, the CV of cluster size is typically close to 0.5,
for instance, 0.4 in a smoking prevention trial [6] and
a stress management trial [7] and 0.6 in a study of general
practice size in the United Kingdom [23]. The minRE is
then near 0.90, giving an increase of the budget and number
of clusters with about 10% only.5. Example
Optimal design will be illustrated for a cluster random-
ized trial on the effect of a training of general practitioners
and nurses on the lifestyle and clinical status of patients
with newly diagnosed type 2 diabetes [4]. The trial included
41 general practices and 250 patients, giving an average
cluster size of 6. Anticipated effect size and ICC were
not reported, but the ICC was found to be 0.05 for body
mass index and clinical status as measured by percentage
of glycated hemoglobin, two of the outcomes. No informa-
tion on the cost ratio c/s is available from this trial, and the
only publication stating costs that we know of reports a cost
ratio of 26 [24] (p. 165). So let us start with a cost ratio of
20 and compare the optimal and actual designs. We then
consider other cost ratios and ICC values and practical
problems and solutions.
Assume as costs c5 200 per cluster and s5 10 per per-
son so that the cost ratio is 20. Furthermore, assume an ICC
of r5 0.05 as found in the diabetes trial. The actual design
with 41 practices of six included patients each then needs
a budget B5 10,660 (GBP, Euro, USD). The optimal sam-
ple size per practice is, however, n5 19 patients by Equa-
tion (2), which allows the inclusion of K5 27 clusters for
almost the same budget, that is, B5 10,530. Following
Equation (1), the optimal design has a DE of 1.90 and ef-
fective sample size of (27 19) / 1.95 270 patients, givinga power of 90% to detect an effect d5 0.40. To have this
same power, the actual design with n5 6 patients per prac-
tice needs 57 instead of 41 practices, requiring a budget
B5 14,820, which is 41% more than that needed by the op-
timal design. It can be shown that this ratio of the budgets
needed for both designs does not depend on the effect size,
power, type I error rate, or absolute costs c and s but de-
pends only on the cost ratio c/s and the ICC.
This is just one example, assuming a cost ratio of 20 and
an ICC of 0.05. To compare the actual and optimal designs
in a more systematic way, Table 1 lists the number of prac-
tices and the budget needed for both designs to have a power
of 90% for an effect size d5 0.50 (medium effect size [13])
at a two-tailed type I error rate of 0.05 for various ICC
values and cost ratios. In particular, assuming the ICC
and costs of the diabetes example, we need 35 clusters of
six patients (actual) or 17 clusters of 19 patients (optimal),
requiring a budget B5 9,100 (actual) vs. B5 6,630 (opti-
mal). More generally, note that the optimal sample size
per practice is between 7 and 70 for all cost ratios from 5
to 50 and all ICCs from 0.01 to 0.10 (Equation (2)). The
actual sample size per practice was on average 6 in the
diabetes trial [4] compared with 110 in a depression trial
[5], suggesting room for improvement in trial design.
Let us now turn to the problem of an unknown ICC for
planning the diabetes trial, assuming as before costs
c5 200 and s5 10, an effect size d5 0.50, a power of
90%, and a5 0.05 two tailed. Take at first, the pessimistic
design for an ICC of 0.10. Following Table 1, we need
K5 28 clusters of size n5 13, giving a total cost
B5 9,240. The midpoint design for an ICC of 0.05 requires
K5 17 clusters of size n5 19, with a total cost B5 6,630,
which is only 72% of the pessimistic design. Now suppose
the ICC turns out to be 0.10 so that the midpoint design was
too optimistic. Its actual DE is then not 1.90 but 2.80, and it
follows from Equation (3) that we need a second stage to
increase the number of clusters to K5 25. The total cost
for the midpoint design is then 9,750, which is only 5.5%
more expensive than the pessimistic design.
Now, with respect to the effect of cluster size variation,
as no information about this variation was available from
the diabetes trial, assume a typical CV of 0.50. The result-
ing loss of efficiency is then restored by adding about 10%
extra clusters, which in turn requires a budget increase of
about 10%.
Apart from the problems of an unknown ICC and vary-
ing cluster size, two other practical problems need to be
discussed. First, the outcome variance and the ICC are
never known beforehand and always estimated from the
data in the final analysis. As a consequence, the test statistic
for the treatment effect follows a Student t-distribution with
df5 K 2 [11], giving slightly less power than by Equa-
tion (3), which assumes a z-distribution. Calculations for
K from 10 to 100 and for power levels of 80% and 90%
show that this power loss is compensated by increasing
the number of clusters by two if a5 0.05 or by four if
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again an effect size d5 0.50, ICC5 0.05, costs c5 200
and s5 10, a power of 90%, and a5 0.05 two tailed, the
number of clusters thus becomes K5 19 instead of 17 (op-
timal) and 37 instead of 35 (actual), requiring budgets
B5 7,410 (optimal) and 9,620 (actual), respectively.
Finally, the optimal design may not be feasible. For in-
stance, it may be difficult to include the optimal number of
patients per practice within the time frame of the study.
This can then be compensated by including more prac-
tices. Or, there may not be enough general practices within
reachable distance. A larger sample size per practice then
offers some compensation, although the increasing DE de-
stroys part of the gains obtained by a larger n (Equation
(1)). Fortunately, as Fig. 1 shows, the SE curves are flat
near their minima, and so a modest deviation from the op-
timal design hardly affects the power and precision. This is
also visible in Table 1, where the actual n5 6 for the di-
abetes trial is hardly more expensive than the optimal
n5 10 for a cost ratio of 5 and ICC of 0.05. So if the op-
timal design is not feasible, one can choose from all fea-
sible designs the one which is closest to the optimal
design in terms of K and n and adapt either K or n (which-
ever can be adapted) to approximate the power for the op-
timal design. This can be done with Equation (3), which
gives the number of clusters K needed for a given cluster
size n, whether this n is the optimum according to Equa-
tion (2) or not. Equation (3) can also be rewritten such that
it gives the required cluster size n for a given number of
clusters K (see equation (14) in the study by Hemming
et al. [25]).6. Discussion
This article showed how efficient sample sizes for clus-
ter randomized trials can be obtained in a simple way. The
optimal sample size per cluster only depends on the cluster-
to-person cost ratio c/s and on the ICC and is between 7 and
70 if the cost ratio is between 5 and 50 and the ICC is be-
tween 0.01 and 0.10. The number of clusters, and thereby
also the sampling budget, additionally depends on the effect
size and power. Using the diabetes trial as example, we
showed that substantive cost reductions can be obtained
by optimal design. Simple and efficient solutions were fur-
thermore given for practical problems in sample size calcu-
lation. The problem of an unknown ICC can be handled by
a two-stage design, with the first stage using the optimal de-
sign for the ICC value halfway the range of plausible
values. The second stage is only needed if the analysis of
the first-stage data shows the ICC to be larger than initially
assumed. Furthermore, the loss of power because of cluster
size variation can be compensated by sampling 10% more
clusters. This article focuses on quantitative outcomes,
but almost the same equations apply to binary outcomes
[26,27]. Furthermore, adding covariates can improve powerby reducing unexplained outcome variance but hardly af-
fects our equations [27].
Just like any other study, this one has limitations to be
overcome by further work. We assumed two treatment
arms, absence of repeated measures, and homogeneity of
variances and costs between arms. Ongoing work is on
treatment-dependent costs and variances, factorial designs
where two treatments are combined, as in the smoking pre-
vention trial [6], and trials with repeated measures, as in the
stress management trial [7]. As a simple example of this
work, it can be shown that if the treatment-to-control cost
ratio is p (O0), both for the cost per cluster level and for
the cost per person, then the optimal treatment-to-control
allocation ratio of clusters is p1/2. So, for instance, if treat-
ment is four times as expensive as control, then we must as-
sign twice as many clusters to control as to treatment.
As will be clear by now, efficient design of cluster ran-
domized trials depends on the availability of information
about outcome variance and sampling cost at each level
of the design (cluster and person). It is therefore important
that publications of cluster randomized trials report not only
the size and significance of the treatment effect of interest
but also the outcome variance, ICC, and sampling costs.
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